GSK plcGSKNYSE
Loading
Cash Flow PerformanceNormalizing
Percentile Rank43
3Y CAGR-3.2%
5Y CAGR-6.9%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-3.2%/yr
vs -5.6%/yr prior
5Y CAGR
-6.9%/yr
Recent acceleration
Acceleration
+2.4pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.06% | +23.8% |
| 2024 | 6.51% | -13.6% |
| 2023 | 7.53% | -15.3% |
| 2022 | 8.89% | -8.0% |
| 2021 | 9.66% | -15.9% |
| 2020 | 11.49% | +39.6% |
| 2019 | 8.24% | -26.4% |
| 2018 | 11.19% | +23.9% |
| 2017 | 9.03% | +33.7% |
| 2016 | 6.76% | - |